 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Dec 13, 2018 |
| Title |
Organoid modeling of the tumor immune microenvironment |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
The interaction of neoplastic cells with their tumor microenvironment (TME) is required for cancer progression. However, in vitro cancer models, including recent in vitro 3-dimensional (3D) organoid cultures of primary human tumors, are typically comprised exclusively of neoplastic epithelium, with stromal and/or immune interactions requiring artificial reconstitution. As relevant to cancer immunotherapy, the unified co-culture of primary tumor epithelia with their endogenous, syngeneic tumor-infiltrating lymphocytes (TILs) as a cohesive unit has remained particularly elusive. Here, we used a single 3D air-liquid interface (ALI) methodology to successfully propagate 3D Patient-Derived Tumor Organoids (PDOs) as primary tumor epithelia together with native immune and myofibroblast stromal compartments without reconstitution. Derived from >100 diverse human surgically resected tumor samples or from murine tumors in syngeneic immunocompetent mice, PDOs preserved cancer histologic subtypes and mutational spectrum with endogenous T, B, NK cells and macrophages integrally embedded amidst the tumor epithelium. PDO-based TILs accurately recapitulated the T cell receptor (TCR) spectrum of the original tumors, as determined by a robust droplet-based immune profiling solution that links gene expression and immune repertoire in single cells. Anti-PD-1 or anti-PD-L1 treatment of organoids from murine tumors from syngeneic immunocompetent hosts induced activation and cytolytic activity of tumor antigen-specific TILs, indicating successful PDO modeling of immune checkpoint blockade (ICB) and anti-tumor immunity. Crucially, the anti-PD-1 antibody nivolumab activated TILs in PDOs from human lung, renal and melanoma clinical tumor resections. The organoid-based propagation of primary tumor epithelium en bloc with its endogenous immune stroma should facilitate mechanistic investigation of TME-specific local tumor immunity, with applications for functional testing of individualized patient immunotherapy responses.
|
| |
|
| Overall design |
Single cell GEX and VDJ profiling from the same samples
|
| |
|
| Contributor(s) |
Zheng G, Zhu J |
| Citation(s) |
30550791 |
| Submission date |
Mar 02, 2018 |
| Last update date |
Mar 21, 2019 |
| Contact name |
Calvin Kuo |
| E-mail(s) |
cjkuo@stanford.edu
|
| Phone |
6504985171
|
| Organization name |
Stanford University
|
| Department |
Department of Medicine, Division of Hematology
|
| Street address |
265 Campus Dr.
|
| City |
Stanford |
| State/province |
CA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (35)
|
|
| Relations |
| BioProject |
PRJNA436710 |
| SRA |
SRP133828 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE111360_RAW.tar |
744.2 Mb |
(http)(custom) |
TAR (of CSV, MTX, TSV) |
| GSE111360_readme_data_processing.txt |
652 b |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
|
|
|
|
 |
Less...
More...